Magazine

Three decades after the first Transcatheter Cardiovascular Therapeutics conference, TCT.18’s organizers are moving “toward a more practical approach,” says Cardiovascular Research Foundation CEO Juan Granada, MD.

Mergers are a lot like arranged marriages in that there’s little or no opportunity for the parties to build relationships before their union is finalized. Building a united team requires much more than a mandate from leadership.

As healthcare shifts from fee-for-service to value-based payment models, practices are experimenting with different ways to measure physicians’ contributions to their practices. Will time value units (TVUs) one day replace relative value units (RVUs)?

With its potential to tap into a myriad of hospital services and departments, hypertrophic cardiomyopathy is drawing interest from medical centers committed to improving the lives of their patients and bolstering the bottom line.

Improving the use of ICDs will involve discerning appropriate from inappropriate shocks, standardizing post-shock protocols and refining device programming.

Interest in Tc 99m PYP is growing as new therapies for cardiac amyloidosis show promise in late-stage clinical trials.

Troponin has become a widely accepted cardiac biomarker for myocardial infarction patients admitted to emergency rooms. But just how reliable is troponin in determining if a heart attack is really a heart attack?

In an era of clinician shortages, those living in rural areas are at risk of not receiving needed care. Cardiologists are stepping up, but will it be enough?

In the U.S., candidates for heart transplantation are prioritized by the intensity of treatment they’ve received, potentially leading some centers to overtreat patients.

In the era of the Quadruple Aim, there’s no shortage of studies, media coverage and commentary on how our healthcare systems may be overusing resources.

The entry of new players and dozens of potentially disruptive mergers and acquisitions are pushing healthcare in nontraditional directions, yielding opportunities for cardiologists to help shape the transformation.

When the prices of two generic medications skyrocketed, health systems worked to rein in costs while ensuring patients continued to receive high-quality care.

Select an Issues